Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Ancient and dominant: a novel feline immunodeficiency virus subtype “X-EGY” identified in Egyptian cats associated with high prevalence
by
Safwat, Mahmoud S.
, Bakry, Noha M.
, Karam, Reham
, Shahen, Nehal M.
, Yousif, Ausama A.
, Bahr, Amany D.
, Khalil, Ghada M.
, Refaei, Omnia H.
, Shehata, Amir A.
, Amer, Haitham M.
, Mansour, Othman N. O.
, Eid, Samah
in
Cats
/ Clade, clinicopathological abnormalities
/ Diseases
/ Distribution
/ Egypt
/ Feline immunodeficiency virus
/ Genetic aspects
/ Identification and classification
/ Medicine
/ Medicine & Public Health
/ Molecular characterization
/ Phylogenetic analysis
/ Prevalence
/ Transgenics
/ Veterinary Medicine/Veterinary Science
/ Zoology
2025
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Ancient and dominant: a novel feline immunodeficiency virus subtype “X-EGY” identified in Egyptian cats associated with high prevalence
by
Safwat, Mahmoud S.
, Bakry, Noha M.
, Karam, Reham
, Shahen, Nehal M.
, Yousif, Ausama A.
, Bahr, Amany D.
, Khalil, Ghada M.
, Refaei, Omnia H.
, Shehata, Amir A.
, Amer, Haitham M.
, Mansour, Othman N. O.
, Eid, Samah
in
Cats
/ Clade, clinicopathological abnormalities
/ Diseases
/ Distribution
/ Egypt
/ Feline immunodeficiency virus
/ Genetic aspects
/ Identification and classification
/ Medicine
/ Medicine & Public Health
/ Molecular characterization
/ Phylogenetic analysis
/ Prevalence
/ Transgenics
/ Veterinary Medicine/Veterinary Science
/ Zoology
2025
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Ancient and dominant: a novel feline immunodeficiency virus subtype “X-EGY” identified in Egyptian cats associated with high prevalence
by
Safwat, Mahmoud S.
, Bakry, Noha M.
, Karam, Reham
, Shahen, Nehal M.
, Yousif, Ausama A.
, Bahr, Amany D.
, Khalil, Ghada M.
, Refaei, Omnia H.
, Shehata, Amir A.
, Amer, Haitham M.
, Mansour, Othman N. O.
, Eid, Samah
in
Cats
/ Clade, clinicopathological abnormalities
/ Diseases
/ Distribution
/ Egypt
/ Feline immunodeficiency virus
/ Genetic aspects
/ Identification and classification
/ Medicine
/ Medicine & Public Health
/ Molecular characterization
/ Phylogenetic analysis
/ Prevalence
/ Transgenics
/ Veterinary Medicine/Veterinary Science
/ Zoology
2025
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Ancient and dominant: a novel feline immunodeficiency virus subtype “X-EGY” identified in Egyptian cats associated with high prevalence
Journal Article
Ancient and dominant: a novel feline immunodeficiency virus subtype “X-EGY” identified in Egyptian cats associated with high prevalence
2025
Request Book From Autostore
and Choose the Collection Method
Overview
Background
Data on the epidemiology and molecular characterization of feline immunodeficiency virus (FIV) in Egypt are limited. This study aimed to estimate FIV prevalence in 240 Egyptian cats during 2022–2024 using three diagnostic techniques: two point-of-care antibody detection kits (Anigen
®
and SNAP
®
) and one end-point PCR targeting the
env
gene. FIV infection is defined as positivity in at least two of the three diagnostic methods or PCR alone confirmed by sequencing, Additionally, FIV-associated clinicopathological abnormalities were assessed, and, for the first time in Egypt, circulating FIV subtypes were identified through partial sequencing and phylogenetic analysis of all
env
gene-positive samples (
n
= 10), along with 4 additional
gag
gene-positive samples.
Results
Using our diagnostic criteria, 76 of 240 cats (31.7%) were identified as FIV-infected. Of these 76 cases, 75 were positive on both rapid kits, yielding a sensitivity of 98.7% for sequential testing with Anigen
®
and SNAP
®
, whereas only 10 were positive on PCR and sequencing (13.2% sensitivity). FIV-infected cats exhibited lymphopenia, thrombocytosis, hyperglobulinemia, and reduced albumin/globulin ratios. On
env
and
gag
gene-based phylogenetic analyses, Egyptian strains did not cluster with any known FIV subtype (A-F and U-NZ
env
) but formed a distinct, previously uncharacterized clade. The Egyptian
env
sequences displayed low intra-group diversity (2.8–3.7%) but high divergence from all known subtypes (21–25%), with no evidence of recombination observed. Moreover, these
env
sequences were derived from both shelter-housed and client-owned cats across three Egyptian governorates within a one-year period.
Conclusion
Given their genetic distinctiveness and widespread detection, we propose a novel FIV subtype, tentatively designated “X-EGY.” Its dominance and limited variability among its strains suggest it represents an ancient lineage uniquely adapted to Egyptian cats, rather than a recently emerged variant. This subtype may partly contribute to Egypt’s notably high FIV prevalence. Serological testing, utilizing two point-of-care kits in screening and confirmation steps, is the most accurate FIV diagnostic approach, outperforming molecular testing, particularly in regions where genetic data on circulating strains are scarce. Overall, the findings enhance our understanding of FIV epidemiology and diagnostic strategies and offer new insights into viral diversity and evolution.
Publisher
BioMed Central,BioMed Central Ltd,BMC
MBRLCatalogueRelatedBooks
Related Items
Related Items
This website uses cookies to ensure you get the best experience on our website.